3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
2
OTHER_GOV
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
133
Stomach Neoplasms
107
Carcinoma, Hepatocellular
73
Rectal Neoplasms
64
Esophageal Neoplasms
53
Pancreatic Neoplasms
52
Colonic Neoplasms
52
Neoplasms
28
Neoplasm Metastasis
20
Esophageal Squamous Cell Carcinoma
20
Gastrointestinal Neoplasms
19
Cholangiocarcinoma
14
Liver Neoplasms
13
Breast Neoplasms
13
Barrett Esophagus
9
Lung Neoplasms
8
Adenoma
8
Motor Activity
7
Liver Cirrhosis
7
Digestive System Neoplasms
7
Colonic Polyps
7
Adenomatous Polyposis Coli
7
Biliary Tract Neoplasms
6
Anastomotic Leak
6
Sarcopenia
5
Inflammatory Bowel Diseases
5
Hypertension, Portal
5
Gallbladder Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Uterine Cervical Neoplasms
4
Interventions
Raltegravir Potassium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Hepatic Insufficiency
×
Gastrointestinal
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled